PDC*line Pharma

PDC*line Pharma est membre de Lyonbiopôle

General information

29 avenue des Maquis du Grésivaudan

La Tronche 38701

Incorporated in: 2014/04/01

Number of employees: 5


More information

 

Main activity

PDC*line Pharma is a clinical-stage biotech that develops potent and scalable off-the-shelf therapeutic cancer vaccines based on the only cell line of Dendritic Cells for therapeutic use (PDC*line). Spin-off of the EFS (French blood service), PDC*line Pharma was founded in 2014 and won national awards including the first start-up prize of MATWINl in 2017, and the first life sciences prize of Tremplin Entreprises 2015.


Funding

Looking for funding: Yes

Nature of funding searches: PDC line Pharma is currently raising funds to conduct its clinical proof-of-concept studies as of 2018

Public funding obtained: 620 k€ in grants

Segmentation
Activities
Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Human Medicine


Application market
Oncology


Activities
Therapeutics, Pharma or Biotech


Technologies
Cell Therapy - cell biology - Biobanking - Vaccine